196 related articles for article (PubMed ID: 33133514)
1. Efficacy of a novel double-controlled oncolytic adenovirus driven by the Ki67 core promoter and armed with IL-15 against glioblastoma cells.
Zhang Q; Zhang J; Tian Y; Zhu G; Liu S; Liu F
Cell Biosci; 2020; 10():124. PubMed ID: 33133514
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells loaded with Ad5-Ki67/IL-15 enhance oncolytic adenovirotherapy in experimental glioblastoma.
Wang P; Zhang J; Zhang Q; Liu F
Biomed Pharmacother; 2023 Jan; 157():114035. PubMed ID: 36434955
[TBL] [Abstract][Full Text] [Related]
3. Ki67-targeted oncolytic adenovirus expressing IL-15 improves intratumoral T cell infiltration and PD-L1 expression in glioblastoma.
Zhang Q; Zhang J; Tian Y; Wang J; Jin G; Liu F
Virology; 2023 Oct; 587():109885. PubMed ID: 37738842
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of an Oncolytic Adenovirus Driven by a Chimeric Promoter and Armed with Decorin Against Renal Cell Carcinoma.
Zhang W; Zhang C; Tian W; Qin J; Chen J; Zhang Q; Fang L; Zheng J
Hum Gene Ther; 2020 Jun; 31(11-12):651-663. PubMed ID: 32216478
[TBL] [Abstract][Full Text] [Related]
5. TS-2021, a third-generation oncolytic adenovirus that carried Ki67 promoter, TGF-β2 5'UTR, and IL-15 against experimental glioblastoma.
Wang J; Zhang J; Zhang Q; Zhang W; Zhang Q; Jin G; Liu F
J Med Virol; 2024 Jan; 96(1):e29335. PubMed ID: 38149454
[TBL] [Abstract][Full Text] [Related]
6. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
7. Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67-siRNA on renal cancer cell.
Liu J; Fang L; Cheng Q; Li L; Su C; Zhang B; Pei D; Yang J; Li W; Zheng J
Cancer Sci; 2012 Oct; 103(10):1880-8. PubMed ID: 22775978
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells.
Fang L; Cheng Q; Li W; Liu J; Li L; Xu K; Zheng J
Virus Res; 2014 Mar; 181():61-71. PubMed ID: 24463503
[TBL] [Abstract][Full Text] [Related]
9. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma.
Huang J; Zheng M; Zhang Z; Tang X; Chen Y; Peng A; Peng X; Tong A; Zhou L
Cancer Immunol Immunother; 2021 Sep; 70(9):2453-2465. PubMed ID: 33543339
[TBL] [Abstract][Full Text] [Related]
11. Double-modified oncolytic adenovirus armed with a recombinant interferon-like gene enhanced abscopal effects against malignant glioma.
Jiang S; Chai HH; Fang XL; Xu HS; Li TW; Tang QS; Gu JF; Zhang KJ; Liu XY; Shi ZF; Cao XP; Wu ZY; Zhou LF
Neurooncol Adv; 2023; 5(1):vdad117. PubMed ID: 37841695
[TBL] [Abstract][Full Text] [Related]
12. The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
Xiao LL; Wu YM; Qian J; Tan Y; Xie GL; Zhang KJ; Wang YG; Jia XY; Liu XY
Cancer Biol Ther; 2010 Aug; 10(3):242-50. PubMed ID: 20574150
[TBL] [Abstract][Full Text] [Related]
13. CCL21/IL21-armed oncolytic adenovirus enhances antitumor activity against TERT-positive tumor cells.
Li Y; Li YF; Si CZ; Zhu YH; Jin Y; Zhu TT; Liu MY; Liu GY
Virus Res; 2016 Jul; 220():172-8. PubMed ID: 27157859
[TBL] [Abstract][Full Text] [Related]
14. Optimization of an E1A Gene Expression Cassette in an Oncolytic Adenovirus for Efficient Tumor Cell Killing Activity.
Sakurai F; Nishimae F; Takayama K; Mizuguchi H
Anticancer Res; 2021 Feb; 41(2):773-782. PubMed ID: 33517282
[TBL] [Abstract][Full Text] [Related]
15. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
[TBL] [Abstract][Full Text] [Related]
16. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
[TBL] [Abstract][Full Text] [Related]
17. A hypoxia- and telomerase-responsive oncolytic adenovirus expressing secretable trimeric TRAIL triggers tumour-specific apoptosis and promotes viral dispersion in TRAIL-resistant glioblastoma.
Oh E; Hong J; Kwon OJ; Yun CO
Sci Rep; 2018 Jan; 8(1):1420. PubMed ID: 29362367
[TBL] [Abstract][Full Text] [Related]
18. Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells.
Lei J; Jacobus EJ; Taverner WK; Fisher KD; Hemmi S; West K; Slater L; Lilley F; Brown A; Champion B; Duffy MR; Seymour LW
J Immunother Cancer; 2018 Jun; 6(1):55. PubMed ID: 29898782
[TBL] [Abstract][Full Text] [Related]
19. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
20. Analysis of adenovirus trans-complementation-mediated gene expression controlled by melanoma-specific TETP promoter in vitro.
Fontecedro AC; Lutschg V; Eichhoff O; Dummer R; Greber UF; Hemmi S
Virol J; 2010 Jul; 7():175. PubMed ID: 20670430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]